Lexicon Pharmaceuticals

Jump to: navigation, search
Lexicon Pharmaceuticals
TypePublic (Template:Nasdaq)
FoundedThe Woodlands, TX, 1995
HeadquartersThe Woodlands, Princeton, New Jersey ,
Template:Country data USA USA
Key peopleArthur T. Sands, CEO
Alan J. Main, VP
IndustryHealth Care
Employees600 (2007)
SloganDiscovering Breakthrough Treatments For Human Disease
Websitewww.lexpharma.com

Lexicon Genetics is a medium sized biopharmaceuticals company that started operation in 1995 in The Woodlands, Texas. Lexicon genetics changed it's name in 2007 to Lexicon Pharmaceuticals (Nasdaq LXRX)to showcase itself as a full blown biotech company. The company started during the biotech bubble days as a small startup, based on its patented mouse knockout technology.In June, 2003 Lexicon Genetics purchased a privately owned small chemical library synthesis company, Coelacanth Corporation in Princeton, New Jersey[1] and renamed the newly acquired company as Lexicon Pharmaceuticals Inc. Since 2001, Lexicon's drug discovery program harmoniously operated between biology division (situated in The Woodlands) and medicinal chemistry (in Princeton).

References

Template:Company-stub



Linked-in.jpg